The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients with Reproductive issues (PRISMA) - PRISMA

Study identifier:D3461R00069

ClinicalTrials.gov identifier:NCT06056778

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients with Reproductive issues (PRISMA)

Medical condition

Systemic Lupus Erythematosus

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

628

Study type

Observational

Age

18 Years - 45 Years

Date

Study Start Date: 28 Sept 2023
Primary Completion Date: 17 Jun 2024
Study Completion Date: 17 Jun 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria